Search research articles
Contact Us
Filters
Showing results (581-590 of 599) with videos related to
Page
of 60
Sort By:
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
<i>PMS1</i> as a target for splice modulation to prevent somatic CAG repeat expansion in Huntington's disease
Zachariah L McLean, Dadi Gao, Kevin Correia, et al.
Frontiers in Immunology
|
October 3, 2025
Clinical laboratory analytes and platelet-associated parameters as surrogate markers of subclinical inflammation in latent tuberculosis infection
Sivaprakasam T Selvavinayagam, Adukkadukkam Anusree, Yean K Yong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 23, 2022
Wide-Bandwidth Nanocomposite-Sensor Integrated Smart Mask for Tracking Multiphase Respiratory Activities
Jiao Suo, Yifan Liu, Cong Wu, et al.
Nature Communications
|
April 12, 2024
Splice modulators target PMS1 to reduce somatic expansion of the Huntington's disease-associated CAG repeat
Zachariah L McLean, Dadi Gao, Kevin Correia, et al.
Annals of Epidemiology
|
December 6, 2022
Association of neighborhood segregation with 6-year incidence of metabolic syndrome in the Hispanic community health study/study of Latinos
Catherine M Pichardo, Margaret S Pichardo, Linda C Gallo, et al.
Leukemia
|
April 11, 2008
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
A Hochhaus, M Baccarani, M Deininger, et al.
Nature Genetics
|
May 26, 2025
Base editing of trinucleotide repeats that cause Huntington's disease and Friedreich's ataxia reduces somatic repeat expansions in patient cells and in mice
Zaneta Matuszek, Mandana Arbab, Maheswaran Kesavan, et al.
Leukemia
|
August 30, 2008
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
J Cortes, D-W Kim, E Raffoux, et al.
British Journal of Haematology
|
November 7, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study
F Huguet, A Guerci-Bresler, G Roth-Guepin, et al.
Ebiomedicine
|
December 22, 2020
Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to human
Harriët Schellekens, Cristina Torres-Fuentes, Marcel van de Wouw, et al.
Page
of 60
Search research articles
Search
Showing results (581-590 of 599) with videos related to
Sort By:
Page
of 60
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
<i>PMS1</i> as a target for splice modulation to prevent somatic CAG repeat expansion in Huntington's disease
Zachariah L McLean, Dadi Gao, Kevin Correia, et al.
Frontiers in Immunology
|
October 3, 2025
Clinical laboratory analytes and platelet-associated parameters as surrogate markers of subclinical inflammation in latent tuberculosis infection
Sivaprakasam T Selvavinayagam, Adukkadukkam Anusree, Yean K Yong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 23, 2022
Wide-Bandwidth Nanocomposite-Sensor Integrated Smart Mask for Tracking Multiphase Respiratory Activities
Jiao Suo, Yifan Liu, Cong Wu, et al.
Nature Communications
|
April 12, 2024
Splice modulators target PMS1 to reduce somatic expansion of the Huntington's disease-associated CAG repeat
Zachariah L McLean, Dadi Gao, Kevin Correia, et al.
Annals of Epidemiology
|
December 6, 2022
Association of neighborhood segregation with 6-year incidence of metabolic syndrome in the Hispanic community health study/study of Latinos
Catherine M Pichardo, Margaret S Pichardo, Linda C Gallo, et al.
Leukemia
|
April 11, 2008
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
A Hochhaus, M Baccarani, M Deininger, et al.
Nature Genetics
|
May 26, 2025
Base editing of trinucleotide repeats that cause Huntington's disease and Friedreich's ataxia reduces somatic repeat expansions in patient cells and in mice
Zaneta Matuszek, Mandana Arbab, Maheswaran Kesavan, et al.
Leukemia
|
August 30, 2008
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
J Cortes, D-W Kim, E Raffoux, et al.
British Journal of Haematology
|
November 7, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study
F Huguet, A Guerci-Bresler, G Roth-Guepin, et al.
Ebiomedicine
|
December 22, 2020
Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to human
Harriët Schellekens, Cristina Torres-Fuentes, Marcel van de Wouw, et al.
Page
of 60